Conference programme

Conference home

Search programme

No results were found for the entered search term

Wednesday 29 May (2000 - 2130)

Thursday 30 May (0800 - 0900)

Thursday 30 May (0800 - 1815)

Thursday 30 May (0835 - 0840)

Thursday 30 May (0840 - 0910)

Thursday 30 May (0910 - 0940)

Session details

Federico de Montalvo former President of the Bioethics Committee of Spain, Madrid 

Read more

Thursday 30 May (0940 - 1230)

Session details

Topic one: Shortage of drugs
María Alonso  Lilly Spain, Madrid
Camilla Appelgren  Mannheimer Swartling, Stockholm 
Ruta Pumputiene  Ellex Valiunas, Lithuania

Topic two: The current surge and challenges of digital therapeutics
Adem Koyuncu  Covington, Brussels
Elisa Stefanini  Portolano Cavallo, Milan
Cécile Théard-Jallu  De Gaulle Fleurance & Associés, Paris

Topic three: Financing of advanced new therapies
Mireia Castro  Novartis Spain, Barcelona
Alfonso Gallego  Pfizer, Madrid 

Topic four: E-commerce of medicinal products: Global freedom or national restrictions?
José Fernández Rañada  Garrigues, Madrid 
Markus Schott
 Bär & Karrer, Zurich
Dr Katharina Wodarz  Raue, Berlin

Topic five: Product liability and medical devices
Manuel Durães Rocha  Abreu Advogados, Lisbon
Monika Gattiker  Lanter, Zurich  

Topic six: Gene therapies and orphan drugs - regulatory status and reimbursement
Henar Álvarez  Alnylam Pharmaceuticals, Madrid
Ariadna Padilla  Takeda, Madrid

Topic seven: Re-labelling repackaging and parallel import of medical devices and pharmaceuticals
Maria Cedó  Esteve, Barcelona 
Janine Demont-Reudt  Niederer Kraft Frey, Zurich  
Miguel Ángel Galve  ex GC of Elanco, Madrid

Topic eight: Human research – big data and secondary use of data
Beatriz Cocina Arrieta  Uria Menendez, Madrid
Ioanna Michalopoulou  Michalopoulou & Associates, Athens
Lincoln Tsang Ropes & Gray, London

Topic nine: Deal structures of life sciences transactions
Gustavo Alcocer Lugo  Olivares, México City
Elazar Stein  Medison Pharma, Petach Tikva and Zug, Israel
Emmanuelle Trombe  McDermott, Will & Emery, Paris 

Topic ten: Interplay between regulation and intellectual property - review of Bolar exemption
Rais Amils  Pérez Llorca, Madrid
Özge Atilgan Karakulak  Gün + Partners, Istanbul 
Martin Dræbye Gantzhorn  Bech-Bruun, Copenhagen

Topic eleven: Artificial intelligence and life sciences
James Gallagher  Mason Hayes & Curran, Dublin 
Njeri Mutura  Microsoft, Irvine, California 
Josefine Sommer  Sidley Austin LLP, Brussels

Topic twelve: Trade secrets / confidentiality in R&D collaborations
Dr Hussein Akhavannik  Blank Rome, Washington, District of Columbia
Maarten Schut  Kennedy Van der Laan, Amsterdam

Topic thirteen: Recent landscape on foreign direct investment in medtech/pharma
Per Lagerkvist  MAQS, Stockholm
Irene Fernández Puyol  Gómez-Acebo & Pombo, Madrid

Topic fourteen: Unified patent court – takeaways from the first year
Morten Bruus  Accura, Copenhagen
Francine Le Péchon-Joubert  De Gaulle Fleurance, Paris
Hanna Tilus  Cirio, Stockholm

Topic fifteen: Pharmaceuticals disparagement cases –Interactions with HCPs and regulators from a competition law perspective
Luis Alcover  Faus Moliner, Barcelona
Moisés Ramírez  GSK Spain, Madrid 
Anders Thue Simonsen Vogt Wiig, Oslo

Topic sixteen: Advertising pharmaceuticals - old law for modern information needs
Ariadna Casanueva  Cuatrecasas, Barcelona
Viviana Cervieri  Cervieri Monsuárez, Montevideo
Celine Weber  Walder Wyss, Zurich

Topic seventeen: Securing innovation: Tackling the 21st century epidemic of counterfeiting and intellectual property piracy
Francisco Javier García  Uría Menéndez, Barcelona
Jason Jardine  Knobbe Martens, San Diego, California
Luis Ruiz BPL, Guatemala City

Read more

Thursday 30 May (1300 - 1345)

Thursday 30 May (1600 - 1615)

Thursday 30 May (1930 - 2300)

Friday 31 May (0800 - 0900)

Friday 31 May (0800 - 1230)

Friday 31 May (0830 - 0840)

Friday 31 May (0840 - 0955)

Session details

Rui Santos Ivo  President, of the Executive Board of Infarmed, Lisbon

Read more